AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 27206212
Drug: Dexmedetomidine (1μg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexmedetomidine (1μg/kg 10min before anesthesia induction, maintain dose 0.4μg/(kg/h))
Trial: 19157672
Drug: 10% carbamide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10% carbamide peroxide bleaching agent
Trial: 15942709
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg rabeprazole
Trial: 27612149
Drug: Ingenol mebutate
RxNorm normalized name: Ingenol Mebutate
DrugBank: Ingenol mebutate (DB05013)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ingenol mebutate 0.05% gel
Trial: 15148065
Drug: Rosiglitazone (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rosiglitazone (4 mg/d)
Trial: 18690305
Drug: Metformin (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin (500 mg bid)
Trial: 9014745
Drug: High-dose melphalan
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose melphalan with G-CSF-primed unprocessed whole blood
Trial: 6760969
Drug: Five days
RxNorm normalized name: fivehorn smotherweed pollen extract
DrugBank: Bassia hyssopifolia pollen (DB10941)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Five days of cefuroxime prophylaxis (0.75 gm three times a day, the first dose being given postoperatively)
Trial: 9738752
Drug: No prophylactic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No prophylactic antibiotics (control group)
Trial: 31322914
Drug: Immunosuppression, anti-arrhythmic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immunosuppression, anti-arrhythmic medications, heart failure medications, device therapy, ablation therapy, heart transplantation
Trial: 29330636
Drug: CT-P6 (6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CT-P6 (6 mg/kg, 90 min intravenous infusion)
Trial: 19445704
Drug: Compliance with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Compliance with treatment allocations
Trial: 15097246
Drug: Nifedipine GITS
RxNorm normalized name: Nifedipine
DrugBank: Nifedipine (DB01115)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nifedipine GITS (20 mg/day for 4 weeks)
Trial: 9652433
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose (3.2 x 10(8) cfu)
Trial: 9652433
Drug: Very low
RxNorm normalized name: Very low fat spread
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Very low dose (1.6 x 10(5) cfu)
Trial: 9652433
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose (3.2 x 10(6) cfu)
Trial: 9652433
Drug: Standard dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard dose (1.6 x 10(8) cfu)
Trial: 8205868
Drug: Single dose
RxNorm normalized name: Citrucel Single Dose Packets (Orange)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single dose regimen C: 1,000 micrograms at bedtime
Trial: 936954
Drug: 2 g
RxNorm normalized name: Molds 2 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 g cephalothin at the induction of anesthesia and another 2 g, 5 and 10 hours after the primary infusion (treatment group)
Trial: 30395961
Drug: Sodium hyaluronate
RxNorm normalized name: sodium hyaluronate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sodium hyaluronate and carboxymethyl cellulose solution (HA‐CMC sol)
Trial: 18438228
Drug: Experimental energy
RxNorm normalized name: Senergy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Experimental energy patches
Trial: 29885904
Drug: Olanzapine 10
RxNorm normalized name: olanzapine 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olanzapine 10 mg
Trial: 8180325
Drug: Unfractionated heparin
RxNorm normalized name: Unfractionated heparin
DrugBank: Heparin (DB01109)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Unfractionated heparin (5,000 U twice a day for at least 6 days)
Trial: 3724174
Drug: Nonthyroxine treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nonthyroxine treatment (control group)
Trial: 8860065
Drug: aspecific treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: aspecific treatment
Trial: 1632114
Drug: 2 ml
RxNorm normalized name: ethanol 2 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 ml of 0.9% NaCl i.v. (Control)
Trial: 22453865
Drug: First-generation antipsychotic
RxNorm normalized name: benzethonium chloride / lidocaine hydrochloride Topical Gel [Tecnu First Aid]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: First-generation antipsychotic drugs (FGAs) - perphenazine and haloperidol
Trial: 22453865
Drug: Second-generation antipsychotic
RxNorm normalized name: regenerated cellulose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Second-generation antipsychotic drugs (SGAs) - olanzapine and clozapine
Trial: 15999421
Drug: Topical application
RxNorm normalized name: Talc Topical application Powder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical application of hyaluronic acid (HA) 5 times daily for 1 week
Trial: 15025555
Drug: Aprepitant (125mg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aprepitant (125mg day 1, 80mg once daily on days 2 and 3 or 2-5) plus standard therapy (intravenous ondansetron and oral dexamethasone)
Trial: 8080985
Drug: Standard therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard therapy plus placebo
Trial: 12784346
Drug: Aprepitant plus
RxNorm normalized name: Aprepitant
DrugBank: Aprepitant (DB00673)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aprepitant plus standard therapy
Trial: 8166188
Drug: Persistent or
RxNorm normalized name: Medicated Pad or Tape
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Persistent or recurrent sialidase 8 weeks after treatment
Trial: 25988461
Drug: Oral prednisone
RxNorm normalized name: Prednisone
DrugBank: Prednisone acetate (DB14646)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral prednisone (tapering 15-day course: 60 mg for 5 days, 40 mg for 5 days, 20 mg for 5 days; total cumulative dose = 600 mg; n=181)
Trial: 25988461
Drug: Oral prednisone
RxNorm normalized name: Prednisone
DrugBank: Prednisone acetate (DB14646)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral prednisone (n=181)
Trial: 19466959
Drug: Adapalene 0.1%-BPO
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adapalene 0.1%-BPO 2.5% fixed-dose combination gel
Trial: 18441854
Drug: BPO 2.5%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BPO 2.5% monotherapy
Trial: 16506874
Drug: No physical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No physical therapy (control group)
Trial: 23163825
Drug: Losartan 50
RxNorm normalized name: LOSARTAN 50MG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Losartan 50 mg/day
Trial: 28840750
Drug: Adalimumab (ADA)
RxNorm normalized name: Adalimumab
DrugBank: Adalimumab (DB00051)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Adalimumab (ADA) 10 mg by intra-articular injection
Trial: 28840750
Drug: Hyaluronic acid
RxNorm normalized name: hyaluronic acid
DrugBank: Hyaluronic acid (non-animal stabilized) (DB19175)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hyaluronic acid (HA) 25 mg by intra-articular injection
Trial: 24850106
Drug: Concordant provocation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Concordant provocation during interlaminar epidural steroid injection
Trial: 24850106
Drug: Discordant provocation
RxNorm normalized name: OCTINOXATE 0.072 g in 1 g TOPICAL LIPSTICK [EFFET PARFAIT ROUGE AMPLIFIER AMPLIFYING SPF 15 (ROUGE PROVOCATION) - RED]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Discordant provocation during interlaminar epidural steroid injection
Trial: 24359174
Drug: Serotonin reuptake
RxNorm normalized name: Selective serotonin reuptake inhibitors
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Serotonin reuptake inhibitors (SRIs) - clomipramine and paroxetine
Trial: 12131867
Drug: Pidotimod (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pidotimod (400 mg x 2 daily for 15 days, then 400 mg daily for 20 days)
Trial: 9690761
Drug: Pulsed field
RxNorm normalized name: Field mushroom
DrugBank: Field mushroom (DB15605)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pulsed field gel electrophoresis (PFGE) assay
Trial: 949899
Drug: Clemastine 1
RxNorm normalized name: clemastine 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clemastine 1 mg b.d. for 3 days
Trial: 28556062
Drug: Probiotic combination
RxNorm normalized name: PROBIOTIC COMBINATION CAP/TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Probiotic combination (Lactobacillus plantarum, Lactobacillus brevis, Pediococcus acidilactici), 2 oral tablets per day for 6 weeks
Trial: 28556062
Drug: Placebo (same
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (same tablets without live bacteria), 2 oral tablets per day for 6 weeks
Trial: 26846042
Drug: Manual flat-trim
RxNorm normalized name: phentermine hydrochloride Oral Capsule [Oby-Trim]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Manual flat-trim toothbrush (Oral-B Indicator)
Trial: 11743058
Drug: Combined treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined treatment (reducing sedentary behavior and increasing physical activity)
Trial: 30444283
Drug: Adherence to
RxNorm normalized name: Wong To Yick
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adherence to treatment
Trial: 8498653
Drug: Perfusion flow
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Perfusion flow rate of 2.4 L.min‐1 x m‐2 (Group I)
Trial: 8498653
Drug: Perfusion flow
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Perfusion flow rate of 1.2 L.min‐1 x m‐2 (Group II)
Trial: 27551725
Drug: Monotherapy with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monotherapy with lopinavir/ritonavir (LPV/r‐MT arm)
Trial: 27551725
Drug: Standard antiretroviral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard antiretroviral therapy (cART arm)
Trial: 17136691
Drug: Furosemide (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Furosemide (60 mg) mixed with fresh frozen plasma (FFP)
Trial: 17136691
Drug: Furosemide (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Furosemide (60 mg) mixed with human albumin (HA)
Trial: 30810347
Drug: DR/ER-MPH 100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DR/ER-MPH 100 mg with high-fat meal
Trial: 29779020
Drug: Intravenous acetaminophen
RxNorm normalized name: Acetaminophen
DrugBank: Acetaminophen (DB00316)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous acetaminophen (4 g/day for 72 postoperative hours)
Trial: 20644331
Drug: ezetimibe 10
RxNorm normalized name: ezetimibe 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ezetimibe 10 mg/day for 6 months
Trial: 12362927
Drug: Ivermectin 30
RxNorm normalized name: Ivermectin
DrugBank: Ivermectin (DB00602)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ivermectin 30 mg (three times a week)
Trial: 12362927
Drug: Ivermectin 60
RxNorm normalized name: Ivermectin
DrugBank: Ivermectin (DB00602)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ivermectin 60 mg (three times a week)
Trial: 12362927
Drug: Ivermectin 90
RxNorm normalized name: Ivermectin
DrugBank: Ivermectin (DB00602)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ivermectin 90 mg (single dose)
Trial: 12362927
Drug: Ivermectin 120
RxNorm normalized name: Ivermectin
DrugBank: Ivermectin (DB00602)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ivermectin 120 mg (single dose)
Trial: 2106735
Drug: multi‐dose blood
FDA approved: no
EMA approved: no
PMDA approved: no
Description: multi‐dose blood cardioplegia (BCP)
Trial: 398481
Drug: Cefaclor at
RxNorm normalized name: Cefaclor
DrugBank: Cefaclor (DB00833)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cefaclor at a dose of 20 mg/kg/day
Trial: 31549255
Drug: Fluticasone furoate/vilanterol
RxNorm normalized name: fluticasone furoate/vilanterol 100/25 MCG/INHAL Dry Powder Inhaler, 30 Blisters
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluticasone furoate/vilanterol (FF/VI) 184/22 mcg or 92/22 mcg
Trial: 29714423
Drug: Yijingfang (half
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Yijingfang (half dose, bid) for 3 months
Trial: 29714423
Drug: Wuziyanzong Pills
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Wuziyanzong Pills (9 g, bid) + L‐carnitine oral liquid (10 ml, bid) for 3 months
Trial: 21052638
Drug: PTH(1‐84) (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PTH(1‐84) (100 μg daily, subcutaneous injection)
Trial: 19278378
Drug: Traditional analgesics
RxNorm normalized name: Analgesic Balm GRX
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Traditional analgesics
Trial: 16914234
Drug: One dose
RxNorm normalized name: Next Choice One Dose
DrugBank: Levonorgestrel (DB00367)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: One dose of pediatric inactivated HA vaccine (Avaxim 80) at 6 months of age (Group B)
Trial: 6305546
Drug: Clonidine (0.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clonidine (0.3 mg)
Trial: 24171880
Drug: Gabapentin 300
RxNorm normalized name: gabapentin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gabapentin 300 mg three times a day for three months
Trial: 21303633
Drug: Dual nostril
RxNorm normalized name: Tums Dual Action
DrugBank: Alginic acid (DB13518)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dual nostril administration of 50 U insulin
Trial: 21303633
Drug: Single nostril
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single nostril administration of 50 U insulin
Trial: 9764987
Drug: Ursodeoxycholic acid
RxNorm normalized name: Ursodeoxycholic acid
DrugBank: Ursodeoxycholic acid (DB01586)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ursodeoxycholic acid treatment in primary biliary cirrhosis (9 patients underwent second liver biopsy)
Trial: 29378542
Drug: Annual mass
RxNorm normalized name: annual bluegrass pollen extract
DrugBank: Poa annua pollen (DB10353)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Annual mass drug administration (MDA) with praziquantel and albendazole before the peak schistosomiasis transmission season
Trial: 19537029
Drug: Minimal invasive
RxNorm normalized name: Centipeda minima whole extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Minimal invasive neurosurgery (MG group)
Trial: 2904898
Drug: No antibiotic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No antibiotic treatment (group B)
Trial: 6107932
Drug: Naftidrofuryl (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naftidrofuryl (40 mg i.m. 3-times for 6 days)
Trial: 30075569
Drug: Alendronate 70
RxNorm normalized name: ALENDRONATE 70MG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alendronate 70 mg/vitamin D3 5600 IU (ALN/D5600)
Trial: 30075569
Drug: Calcitriol 0.25
RxNorm normalized name: CALCITRIOL 0.25MCG CAP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcitriol 0.25 mcg
Trial: 25942016
Drug: Power capacities
RxNorm normalized name: guaifenesin
DrugBank: Guaifenesin (DB00874)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Power capacities (Sargent-jump, broad-jump, medicine-ball-throw)
Trial: 23782581
Drug: levobupivacaine 0.125%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: levobupivacaine 0.125% plus fentanyl 4 μg ml‐1 (Group F)
Trial: 23782581
Drug: levobupivacaine 0.125%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: levobupivacaine 0.125% (Group L)
Trial: 19028835
Drug: Thiopental (GABA(A)
DrugBank: Thiopental (DB00599)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Thiopental (GABA(A) receptor agonist)
Trial: 14988822
Drug: Ketamine (NMDA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketamine (NMDA receptor antagonist)
Trial: 6794081
Drug: Naloxone 1.6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naloxone 1.6 mg
Trial: 17579942
Drug: Omeprazole 40
RxNorm normalized name: omeprazole 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole 40 mg for 2 weeks
Trial: 15385381
Drug: Single-injection (Group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single-injection (Group 1)
Trial: 15385381
Drug: Dual-injection (Group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dual-injection (Group 2)
Trial: 27995731
Drug: Insulin isophane
RxNorm normalized name: insulin isophane
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Insulin isophane
Trial: 1406395
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy (colestipol 5 g or 10 g + simvastatin 20 mg/night then 40 mg/night)
Trial: 27332627
Drug: Transdermal Rivastigmine
RxNorm normalized name: rivastigmine Transdermal Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal Rivastigmine
Trial: 15237766
Drug: Montelukast (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Montelukast (10 mg/d)
Trial: 10464834
Drug: Inhaled ceftazidime
RxNorm normalized name: Ceftazidime
DrugBank: Ceftazidime (DB00438)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Inhaled ceftazidime and tobramycin (group A)
Trial: 10464834
Drug: Symptomatic treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Symptomatic treatment (group B)
Trial: 2240724
Drug: Lidocaine (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lidocaine (1 mg/kg IV bolus, followed by 2 mg/min IV drip, with a second bolus of 0.5 mg/kg after 10 minutes)
Trial: 2240724
Drug: Control (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (no lidocaine treatment)
Trial: 350499
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg indomethacin plus 10 mg diazepam
Trial: 350499
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg sulindac
Trial: 350499
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg sulindac plus 10 mg diazepam
Trial: 12688109
Drug: Beclomethasone dipropionate
RxNorm normalized name: Beclomethasone Dipropionate
DrugBank: Beclomethasone dipropionate (DB00394)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beclomethasone dipropionate nasal spray (400 micrograms daily)
Trial: 16504397
Drug: Oral cortisol
RxNorm normalized name: Corticool
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral cortisol (30 mg)
Trial: 25265284
Drug: Both intranasal
RxNorm normalized name: Bothrops atrox venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both intranasal insulin and oral cortisol
Trial: 22464310
Drug: Intradetrusor onabotulinumtoxinA
RxNorm normalized name: Onabotulinumtoxina
DrugBank: Botulinum toxin type A (DB00083)
FDA approved: no
EMA approved: yes
PMDA approved: yes
Description: Intradetrusor onabotulinumtoxinA (doses ≥100 U)
Trial: 17647298
Drug: Sertraline (50‐150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sertraline (50‐150 mg/day) for 6 weeks
Trial: 16291981
Drug: Sibutramine 15
RxNorm normalized name: sibutramine 15 mg oral capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sibutramine 15 mg per day
Trial: 16291981
Drug: Sibutramine plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sibutramine plus lifestyle modification counseling (combined therapy)
Trial: 8749868
Drug: Magnesium sulfate
RxNorm normalized name: Magnesium Sulfate
DrugBank: Magnesium (DB14513)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Magnesium sulfate infusion (8 mmol over 5 min followed by 65 mmol over 24 h)
Trial: 15243278
Drug: Raloxifene (RLX)
DrugBank: Raloxifene (DB00481)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Raloxifene (RLX) 60 mg daily
Trial: 13678475
Drug: Alendronate (ALN)
RxNorm normalized name: alendronate
DrugBank: Alendronic acid (DB00630)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Alendronate (ALN) 70 mg once weekly
Trial: 21254911
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of RLX and ALN
Trial: 8449578
Drug: 700 mg
RxNorm normalized name: cystine 700 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 700 mg pivampicillin tablet with antacid
Trial: 8449578
Drug: 700 mg
RxNorm normalized name: cystine 700 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 700 mg pivampicillin tablet
Trial: 3020162
Drug: Acyclovir (ACV)
RxNorm normalized name: Acyclovir
DrugBank: Acyclovir (DB00787)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Acyclovir (ACV) at 10 mg/kg body weight at 8 h intervals for 7 days
Trial: 31376619
Drug: Insulin glargine
RxNorm normalized name: Insulin Glargine
DrugBank: Insulin glargine (DB00047)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Insulin glargine in Lantus® and Toujeo®
Trial: 27412502
Drug: Short message
RxNorm normalized name: short ragweed pollen extract Sublingual Tablet [Ragwitek]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Short message service (SMS) intervention for drug consumption motivation
Trial: 21534749
Drug: Intravenous low-dose
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intravenous low-dose magnesium sulphate (0.75 g/h after a loading dose of 4 g)
Trial: 21534749
Drug: Standard intramuscular
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard intramuscular regimen (as advocated by Pritchard)
Trial: 21534749
Drug: Intravenous low-dose
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intravenous low-dose magnesium sulphate
Trial: 7798851
Drug: Standard intramuscular
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard intramuscular regimen
Trial: 16438759
Drug: Tranexamic acid
RxNorm normalized name: Tranexamic Acid
DrugBank: Tranexamic acid (DB00302)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tranexamic acid (2 g in 100 mL of saline solution)
Trial: 15372383
Drug: Placebo (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (100 mL of saline)
Trial: 12778857
Drug: Calcium carbonate
RxNorm normalized name: Calcium Carbonate
DrugBank: Calcium carbonate (DB06724)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Calcium carbonate 5 g/day